Davion Healthcare PLC (DAVI) stock
Close on Nov 18, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $1.03
- Open
- $1.13
- Day's range
- $1.04 – $1.18
- Volume
- 118,900
- Average volume (20 days)
- 1,257,640
Press releases
Releases Davion Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Davion Healthcare
Surgical & Medical Instruments & Apparatus
Davion Healthcare Plc is a healthcare technology company focused on developing early-warning, non-invasive Class I medical screening devices. Its product offerings include BreastCheck, an early indicator screening test utilizing thermochromic films, and FootFlow. The company operates through a licensing and distribution commercial model, partnering with regional and global licensees such as NeuRX Health Inc. to manage manufacturing, product marketing, retail distribution, customer support, and warranty obligations. Its target end users comprise individual consumers seeking preventative wellness insights as well as healthcare providers who review test results processed via smartphone applications and proprietary artificial intelligence servers.
Company profile, executives and historyDavion Healthcare stock: common questions
What is Davion Healthcare's stock price?
DAVI closed at $1.07 on Nov 18, 2026, up 3.88% on the day.
Does Davion Healthcare pay a dividend?
No. Davion Healthcare has not paid a cash dividend over the last twelve months.
Who are Davion Healthcare's competitors?
Companies most similar to Davion Healthcare by business, industry and size include PLSM, AMIX, ODYY, INBS, FEMY.
See a number that looks wrong?